TSPT Insider Trading Activity and SEC Form 4 Filings
TSPT insider trading summary
No open-market insider purchases or sales of Transcept Pharmaceuticals Inc (TSPT) have been reported on SEC Form 4 in the past 12 months.
Latest TSPT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 13, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $5K (1,470 @ $3.54) |
| Dec 11, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $2K (500 @ $3.57) |
| Dec 11, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $2K (520 @ $3.53) |
| Dec 10, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $34K (9,470 @ $3.55) |
| Dec 6, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $31K (8,710 @ $3.54) |
| Dec 4, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $19K (5,450 @ $3.50) |
| Dec 3, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $6K (1,670 @ $3.50) |
| Nov 20, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $6K (1,540 @ $3.61) |
| Nov 19, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $11K (3,060 @ $3.55) |
| Nov 18, 2013 | Roumell Asset Management, LLC | 10% Owner | Sell | $19K (5,440 @ $3.57) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.